Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.

Korja M, Raj R, Seppä K, Luostarinen T, Malila N, Seppälä M, Mäenpää H, Pitkäniemi J.

Neuro Oncol. 2018 Oct 12. doi: 10.1093/neuonc/noy164. [Epub ahead of print]

PMID:
30312433
2.

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quirós JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC.

Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.

3.

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Lehtinen M, Luostarinen T, Vänskä S, Söderlund-Strand A, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Nieminen P, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 May 30. doi: 10.1002/ijc.31618. [Epub ahead of print]

PMID:
29845626
4.

The risk of cervical atypia in oral contraceptive users.

Adhikari I, Eriksson T, Luostarinen T, Lehtinen M, Apter D.

Eur J Contracept Reprod Health Care. 2018 Feb;23(1):12-17. doi: 10.1080/13625187.2018.1431214. Epub 2018 Feb 7.

PMID:
29412045
5.

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).

Gray P, Palmroth J, Luostarinen T, Apter D, Dubin G, Garnett G, Eriksson T, Natunen K, Merikukka M, Pimenoff V, Söderlund-Strand A, Vänskä S, Paavonen J, Pukkala E, Dillner J, Lehtinen M.

Int J Cancer. 2018 Jun 15;142(12):2491-2500. doi: 10.1002/ijc.31281. Epub 2018 Feb 12.

PMID:
29377141
6.

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC.

PLoS One. 2017 Dec 27;12(12):e0187741. doi: 10.1371/journal.pone.0187741. eCollection 2017.

7.

Vaccination protects against invasive HPV-associated cancers.

Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, Paavonen J, Pukkala E, Lehtinen M.

Int J Cancer. 2018 May 15;142(10):2186-2187. doi: 10.1002/ijc.31231. Epub 2018 Jan 4. No abstract available.

PMID:
29280138
8.

Adenosine-induced cardiac arrest as an alternative to temporary clipping during intracranial aneurysm surgery.

Intarakhao P, Thiarawat P, Rezai Jahromi B, Kozyrev DA, Teo MK, Choque-Velasquez J, Luostarinen T, Hernesniemi J.

J Neurosurg. 2018 Sep;129(3):684-690. doi: 10.3171/2017.5.JNS162469. Epub 2017 Oct 27.

PMID:
29076786
9.

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Lehtinen M, Söderlund-Strand A, Vänskä S, Luostarinen T, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Mar 1;142(5):949-958. doi: 10.1002/ijc.31119. Epub 2017 Nov 9.

PMID:
29055031
10.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.

BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.

11.

Prone Versus Sitting Position in Neurosurgery-Differences in Patients' Hemodynamic Management.

Luostarinen T, Lindroos AC, Niiya T, Silvasti-Lundell M, Schramko A, Hernesniemi J, Randell T, Niemi T.

World Neurosurg. 2017 Jan;97:261-266. doi: 10.1016/j.wneu.2016.10.005. Epub 2016 Oct 12.

PMID:
27744075
12.

Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.

Karjalainen L, Anttila A, Nieminen P, Luostarinen T, Virtanen A.

BMC Cancer. 2016 Mar 15;16:221. doi: 10.1186/s12885-016-2246-9.

13.

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study.

Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):721-4. doi: 10.1158/1055-9965.EPI-15-1290. Epub 2016 Feb 9.

14.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J.

Acta Oncol. 2016 Jul;55(7):839-45. doi: 10.3109/0284186X.2016.1139178. Epub 2016 Feb 15.

PMID:
26878091
15.

Clean, fast and preserving normal anatomy: "the Helsinki revolution" in microneurosurgery.

Velasquez JC, Lau J, Kozyrev D, Sharafeddin F, Colasanti R, Luostarinen T, Hernesniemi J.

J Neurosurg Sci. 2016 Mar;60(1):44-53. Epub 2015 Nov 24. Review.

16.

Transient Cardiac Arrest Induced by Adenosine: A Tool for Contralateral Clipping of Internal Carotid Artery-Ophthalmic Segment Aneurysms.

Andrade-Barazarte H, Luostarinen T, Goehre F, Kivelev J, Jahromi BR, Ludtka C, Lehto H, Raj R, Ibrahim TF, Niemela M, Jääskeläinen JE, Hernesniemi JA.

World Neurosurg. 2015 Dec;84(6):1933-40. doi: 10.1016/j.wneu.2015.08.038. Epub 2015 Sep 2.

PMID:
26341426
17.

Transfusion Frequency of Red Blood Cells, Fresh Frozen Plasma, and Platelets During Ruptured Cerebral Aneurysm Surgery.

Luostarinen T, Lehto H, Skrifvars MB, Kivisaari R, Niemelä M, Hernesniemi J, Randell T, Niemi T.

World Neurosurg. 2015 Aug;84(2):446-50. doi: 10.1016/j.wneu.2015.03.053. Epub 2015 Apr 1.

PMID:
25839398
18.

Self-sampling experiences among non-attendees to cervical screening.

Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A.

Gynecol Oncol. 2014 Dec;135(3):487-94. doi: 10.1016/j.ygyno.2014.09.019. Epub 2014 Oct 2.

PMID:
25284037
19.

Improving cervical cancer screening attendance in Finland.

Virtanen A, Anttila A, Luostarinen T, Malila N, Nieminen P.

Int J Cancer. 2015 Mar 15;136(6):E677-84. doi: 10.1002/ijc.29176. Epub 2014 Sep 15.

20.

Measuring the accuracy of automatic shoeprint recognition methods.

Luostarinen T, Lehmussola A.

J Forensic Sci. 2014 Nov;59(6):1627-34. doi: 10.1111/1556-4029.12474. Epub 2014 May 20.

PMID:
24846765
21.

Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening.

Sarkeala T, Luostarinen T, Dyba T, Anttila A.

Springerplus. 2014 Jul 8;3:348. doi: 10.1186/2193-1801-3-348. eCollection 2014.

22.

[Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].

Virtanen A, Nieminen P, Malila N, Luostarinen T, Anttila A.

Duodecim. 2013;129(16):1709-17. Finnish.

PMID:
24069641
23.

Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.

Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J.

Int J Cancer. 2013 Oct 15;133(8):1840-5. doi: 10.1002/ijc.28188. Epub 2013 Apr 25.

24.

Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study.

Luostarinen T, Namujju PB, Merikukka M, Dillner J, Hakulinen T, Koskela P, Paavonen J, Surcel HM, Lehtinen M.

Int J Cancer. 2013 Oct 1;133(7):1756-9. doi: 10.1002/ijc.28173. Epub 2013 Apr 17.

25.

Long-term excess mortality of patients with treated and untreated unruptured intracranial aneurysms.

Pyysalo L, Luostarinen T, Keski-Nisula L, Öhman J.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):888-92. doi: 10.1136/jnnp-2012-303073. Epub 2013 Feb 19.

26.

Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up.

Rana MM, Huhtala H, Apter D, Eriksson T, Luostarinen T, Natunen K, Paavonen J, Pukkala E, Lehtinen M.

Int J Cancer. 2013 Jun 15;132(12):2833-8. doi: 10.1002/ijc.27971. Epub 2012 Dec 19.

27.

Mortality audit of the Finnish cervical cancer screening program.

Lönnberg S, Nieminen P, Luostarinen T, Anttila A.

Int J Cancer. 2013 May 1;132(9):2134-40. doi: 10.1002/ijc.27844. Epub 2012 Oct 12.

28.

Age-specific effectiveness of the Finnish cervical cancer screening programme.

Lönnberg S, Anttila A, Luostarinen T, Nieminen P.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1354-61. doi: 10.1158/1055-9965.EPI-12-0162. Epub 2012 Jun 4.

29.

Thromboelastometry during intraoperative transfusion of fresh frozen plasma in pediatric neurosurgery.

Luostarinen T, Silvasti-Lundell M, Medeiros T, Romani R, Hernesniemi J, Niemi T.

J Anesth. 2012 Oct;26(5):770-4. doi: 10.1007/s00540-012-1400-z. Epub 2012 May 6.

PMID:
22562643
30.

Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer.

Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.

Am J Epidemiol. 2012 Apr 1;175(7):685-95. doi: 10.1093/aje/kwr373. Epub 2012 Mar 14.

PMID:
22419740
31.

Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively.

Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Törnberg S, Tryggvadottir L.

Eur J Public Health. 2011 Dec;21(6):686-7. doi: 10.1093/eurpub/ckr149. Epub 2011 Nov 10. No abstract available.

PMID:
22080476
32.

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.

Arnheim Dahlström L, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, Wiklund F, Skare GB, Eklund C, Sjölin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2541-50. doi: 10.1158/1055-9965.EPI-11-0761. Epub 2011 Oct 12.

33.

Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.

Virtanen A, Nieminen P, Luostarinen T, Anttila A.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1960-9. doi: 10.1158/1055-9965.EPI-11-0307. Epub 2011 Jul 13.

34.

Comparison of hypertonic saline and mannitol on whole blood coagulation in vitro assessed by thromboelastometry.

Luostarinen T, Niiya T, Schramko A, Rosenberg P, Niemi T.

Neurocrit Care. 2011 Apr;14(2):238-43. doi: 10.1007/s12028-010-9475-6.

PMID:
21369792
35.

Large performance variation does not affect outcome in the Finnish cervical cancer screening programme.

Lönnberg S, Nieminen P, Kotaniemi-Talonen L, Kujari H, Melkko J, Granroth G, Vornanen M, Pietiläinen T, Arola J, Tarkkanen J, Luostarinen T, Anttila A.

Cytopathology. 2012 Jun;23(3):172-80. doi: 10.1111/j.1365-2303.2011.00849.x. Epub 2011 Jan 24.

PMID:
21255160
36.

Adenosine-induced cardiac arrest during intraoperative cerebral aneurysm rupture.

Luostarinen T, Takala RS, Niemi TT, Katila AJ, Niemelä M, Hernesniemi J, Randell T.

World Neurosurg. 2010 Feb;73(2):79-83; discussion e9. doi: 10.1016/j.surneu.2009.06.018. Epub 2009 Oct 8.

PMID:
20860932
37.

Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.

Virtanen A, Anttila A, Luostarinen T, Nieminen P.

Int J Cancer. 2011 Jun 1;128(11):2681-7. doi: 10.1002/ijc.25581. Epub 2010 Jul 28.

38.

Effect of arterial blood pressure on the arterial to end-tidal carbon dioxide difference during anesthesia induction in patients scheduled for craniotomy.

Luostarinen T, Dilmen OK, Niiya T, Niemi T.

J Neurosurg Anesthesiol. 2010 Oct;22(4):303-8. doi: 10.1097/ANA.0b013e3181e33791.

PMID:
20622686
39.

Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study.

Toriola AT, Surcel HM, Calypse A, Grankvist K, Luostarinen T, Lukanova A, Pukkala E, Lehtinen M.

Eur J Cancer. 2010 Oct;46(15):2799-805. doi: 10.1016/j.ejca.2010.05.019. Epub 2010 Jun 18.

PMID:
20601305
40.

Low proportion of false-negative smears in the Finnish program for cervical cancer screening.

Lönnberg S, Anttila A, Kotaniemi-Talonen L, Kujari H, Melkko J, Granroth G, Vornanen M, Pietiläinen T, Sankila A, Arola J, Luostarinen T, Nieminen P.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):381-7. doi: 10.1158/1055-9965.EPI-09-1038.

41.

Ensuring quality in studies linking cancer registries and biobanks.

Langseth H, Luostarinen T, Bray F, Dillner J.

Acta Oncol. 2010 Apr;49(3):368-77. doi: 10.3109/02841860903447069.

PMID:
20059313
42.

No risk of maternal EBV infection for childhood leukemia.

Tedeschi R, Luostarinen T, Marus A, Bzhalava D, Ogmundsdottir HM, Dillner J, De Paoli P, Surcel HM, Pukkala E, Lehtinen M, Lehtinen T.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2790-2. doi: 10.1158/1055-9965.EPI-09-0751. Epub 2009 Sep 15.

43.

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.

Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Löve A, Mahlamaki E, Thoresen S, Tryggvadóttir L, Wadell G, Youngman L, Lehtinen M.

Am J Epidemiol. 2009 Feb 15;169(4):480-8. doi: 10.1093/aje/kwn354. Epub 2008 Dec 13.

PMID:
19074773
44.

Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study.

Koskinen WJ, Brøndbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, Molijn A, Quint WG, Røysland T, Munck-Wikland E, Mäkitie AA, Pyykkö I, Dillner J, Vaheri A, Aaltonen LM.

J Cancer Res Clin Oncol. 2007 Sep;133(9):673-8. Epub 2007 May 8.

PMID:
17486368
45.

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.

Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J.

Acta Oncol. 2007;46(3):286-307.

PMID:
17450464
46.

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing.

Lehtinen M, Apter D, Dubin G, Kosunen E, Isaksson R, Korpivaara EL, Kyhä-Osterlund L, Lunnas T, Luostarinen T, Niemi L, Palmroth J, Petäjä T, Rekonen S, Salmivesi S, Siitari-Mattila M, Svartsjö S, Tuomivaara L, Vilkki M, Pukkala E, Paavonen J.

Int J STD AIDS. 2006 Aug;17(8):517-21.

PMID:
16925896
47.

Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy.

Lehtinen M, Idänpään-Heikkilä I, Lunnas T, Palmroth J, Barr E, Cacciatore R, Isaksson R, Kekki M, Koskela P, Kosunen E, Kuortti M, Lahti L, Liljamo T, Luostarinen T, Apter D, Pukkala E, Paavonen J.

Int J STD AIDS. 2006 Apr;17(4):237-46.

PMID:
16595046
48.

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.

Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2952-5.

49.

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk.

Tedeschi R, Luostarinen T, De Paoli P, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J.

Br J Cancer. 2005 Oct 3;93(7):834-7.

50.

Chlamydial antibodies and risk of prostate cancer.

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):385-9.

Supplemental Content

Loading ...
Support Center